Researchers are delving into the impacts of long-term thyroid-stimulating hormone suppression on age-related macular degeneration (AMD). A potential connection has been found between elevated thyroxine levels and eyesight deterioration in the elderly, particularly in those with hyperthyroidism who exhibit a higher risk of AMD.